Correlation Between C4 Therapeutics and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Olema Pharmaceuticals, you can compare the effects of market volatilities on C4 Therapeutics and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Olema Pharmaceuticals.
Diversification Opportunities for C4 Therapeutics and Olema Pharmaceuticals
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CCCC and Olema is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Olema Pharmaceuticals
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Olema Pharmaceuticals. In addition to that, C4 Therapeutics is 1.05 times more volatile than Olema Pharmaceuticals. It trades about -0.24 of its total potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.23 per unit of volatility. If you would invest 1,181 in Olema Pharmaceuticals on August 28, 2024 and sell it today you would lose (290.00) from holding Olema Pharmaceuticals or give up 24.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Olema Pharmaceuticals
Performance |
| Timeline |
| C4 Therapeutics |
| Olema Pharmaceuticals |
C4 Therapeutics and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Olema Pharmaceuticals
The main advantage of trading using opposite C4 Therapeutics and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |